Paola Giusti-Rodriguez

Paola Giusti-Rodriguez, PhD

Assistant Professor

Business Phone: (352) 294-4880
Business Email:

About Paola Giusti-Rodriguez

Dr. Paola Giusti-Rodriguez grew up in San Juan, Puerto Rico, where she earned a BS in Biology at the University of Puerto Rico-Rio Piedras. She completed her PhD in Cell and Developmental Biology at Harvard University, where her doctorate research focused on studying the molecular basis of neurodegeneration.

Dr. Giusti-Rodriguez carried out her postdoctoral research with Dr. Patrick Sullivan at the University of North Carolina at Chapel Hill, where she employed the multi-parental Collaborative Cross mouse population to better understand antipsychotic side effects. Her work lies at the intersection between neuroscience and functional genomics, and she aims to integrate the tools and techniques of these fields to shed light on the genetics of neuropsychiatric disorders.

In 2016, she was awarded a K01 Mentored Research Scientist Development Award by the National Institute of Mental Health for her work focused on functional genomics of psychiatric disorders. Dr. Giusti-Rodriguez is co-founder of the Latin American Genomics Consortium, which seeks to increase the representation of research participants from Latinx admixed ancestry in genetic studies on psychiatric disorders.

Dr. Giusti-Rodriguez works in the Adult Research Division and will conduct research in genetic psychiatric illnesses, with interest in human-based studies of neurodevelopmental disorders (including ASD and schizophrenia), at the UF Center for OCD, Anxiety and Related Disorders (COARD). In addition, she serves as an important academic teacher and mentor for medical students, interns, training residents and promoting the research and educational mission of the McKnight Brain Institute (MBI) for Department of Psychiatry.


ASHG Human Genetics Scholar
2019 · American Society of Human Genetics
MINDS Class of 2017
2017 · Mentoring Institute for Neuroscience Diversity Scholars (MINDS)
North Coast Conference on Precision Medicine Travel Award
2017 · North Coast Conference on Precision Medicine


Correction: Common-variant associations with fragile X syndrome.
Molecular psychiatry. 25(12) [DOI] 10.1038/s41380-019-0526-x. [PMID] 31548576.
Increased burden of ultra-rare structural variants localizing to boundaries of topologically associated domains in schizophrenia.
Nature communications. 11(1) [DOI] 10.1038/s41467-020-15707-w. [PMID] 32296054.
Common-variant associations with fragile X syndrome.
Molecular psychiatry. 24(3):338-344 [DOI] 10.1038/s41380-018-0290-3. [PMID] 30531935.
Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects.
Molecular psychiatry. 23(3):708-712 [DOI] 10.1038/mp.2017.111. [PMID] 28555076.
Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia.
Nature communications. 9(1) [DOI] 10.1038/s41467-018-05379-y. [PMID] 30087329.
Genetic identification of brain cell types underlying schizophrenia.
Nature genetics. 50(6):825-833 [DOI] 10.1038/s41588-018-0129-5. [PMID] 29785013.
The Mouse Universal Genotyping Array: From Substrains to Subspecies.
G3 (Bethesda, Md.). 6(2):263-79 [DOI] 10.1534/g3.115.022087. [PMID] 26684931.
A meta-analysis of gene expression quantitative trait loci in brain.
Translational psychiatry. 4 [DOI] 10.1038/tp.2014.96. [PMID] 25290266.


Ph.D. Cell and Developmental Biology
2011 · Harvard University
B.S. Biology
2003 · University of Puerto Rico-Río Piedras

Contact Details

(352) 294-4880